← Browse by Condition
Medical Condition
adolescent
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT05887973
Recruiting
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
Enrollment
250 pts
Location
United States
Sponsor
University of Michigan
NCT06563245 Phase 2, Phase 3
Recruiting
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Enrollment
96 pts
Location
China
Sponsor
Children's Cancer Group, China